See our FAQ page for additional product information
The following is a brief summary of available data from the PIONEER 1-8 studies
If the medicine doesnt work for me or my insurance doesnt cover it, what other options do I have
Others include glucose-dependent insulinotropic polypeptide (GIP), ghrelin, peptide YY (PYY) and pancreatic polypeptide (PP) (1)
However, the researchers did a sensitivity analysis of a 50 mg version and found that it was not as effective as tirzepatide in non-diabetic patients looking to lose weight
A randomized controlled trial showed that GLP-1RAs prevents the decline of cerebral metabolic rate for glucose (CMRglc) in AD, and GLP-1RAs may increase the expression of glucose transporters (e.g., GLUT1) at the blood-brain barrier (BBB) (Mullins et al., 2019)